Alaunos Therapeutics to Participate in Upcoming Investor : v

HOUSTON, March 29, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a leading T-cell receptor (TCR) cell...

Related Keywords

Houston , Texas , United States , Alex Lobo , Heather Anderson , Alaunos Therapeutics Inc , National Cancer Institute , Company Nasdaq , Company Presentation , National Institutes Of Health , Oncology Virtual , Fireside Chat , Annual Needham Virtual Healthcare , Sleeping Beauty , National Institutes , Relations Contact , Nasdaq Tcrt , Alaunos Therapeutics , Nc ,